$21.4M in CY2024 Part D spend18K claims · 5K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Adalimumab-Bwwd used for?
Adalimumab-Bwwd suppresses inflammation by blocking tumor necrosis factor, used in autoimmune conditions.
Is there a generic for Adalimumab-Bwwd?
No. Adalimumab-Bwwd is brand-only with no generic equivalents currently in market.
How much does my plan pay for Adalimumab-Bwwd?
Across 329 Part D plans, Adalimumab-Bwwd averages $940.93/unit (NADAC). Lowest available: $611.35/unit. Highest in distribution: $1261.09/unit.
Is Adalimumab-Bwwd on the FDA shortage list?
No. Adalimumab-Bwwd is not currently on the FDA Drug Shortage Database.
6 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (4 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.